We are working on the following new projects:

• Smooth won a bidding for the international phase III clinical trial of the original drug for the patients with chronic myeloid leukemia. The study will take place in India, Belarus, and Russia.
• We started two projects for medical writing (INN: Diacerein and Trimebutine) and one for data management (INN: Aethylmethylhydroxypyridini succinas) for our Russian-based Sponsor.
• We were awarded with a BE trial in Otilium Bromide by the Czech Sponsor and now we are finalizing the Work Order.
• We are starting activities for a new phase III COVID-19 vaccine trial.

We are happy to reach the following milestones in our projects:

• Сlinical part in the Dasatinib trial was finished.
• The enrollment is being performed quickly in phase II COVID-19 the study.